Asia-Pacific
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Law firms across the world are seemingly united in their reluctance to give juniors a chance, which shouldn’t be the case
Sponsored
Sponsored
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law summarises the eligible drugs, the re-examination period and strategies available for companies -
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners previews potential suggested changes to Japan’s patent world
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula of RNA, Technology and IP Attorneys takes a look at the new due diligence mechanism and considers why this has caused a backlash
-
Sponsored by CCPIT Patent and Trademark Law OfficeGang Hu of CCPIT Patent and Trademark Law Office discusses the Economic and Trade Agreement between China and the US regarding the protection of geographical indications
-
Sponsored by LexOrbisManisha Singh and Pankaj Musyuni of LexOrbis discuss regulatory changes for medical device companies and the impact of COVID-19 on manufacturers
-
Sponsored by Remfry & SagarBisman Kaur and Raashi Jain of Remfry & Sagar discuss how key judicial decisions have shaped trademark protection in India’s automotive industry
